These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 217836)

  • 21. [In-vitro activity of mecillinam against urine isolates of Escherichia coli from outpatient departments in Germany].
    Kresken M; Körber-Irrgang B; Naber KG
    Aktuelle Urol; 2017 May; 48(3):243-247. PubMed ID: 28427111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro susceptibility to mecillinam of Escherichia coli strains isolated from the urine of pregnant women.
    Duployez C; Loiez C; Cattoen C; Descamps D; Wallet F; Vachée A;
    Med Mal Infect; 2016 Dec; 46(8):436-441. PubMed ID: 27609597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pivmecillinam in treatment of Staphylococcus saprophyticus urinary tract infections.
    Granlund M; Landgren E; Henning C
    Scand J Infect Dis; 1983; 15(1):65-9. PubMed ID: 6302831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum levels of mecillinam in patients with severely impaired renal function.
    Svarva PL; Wessel-Aas T
    Scand J Infect Dis; 1980; 12(4):303-5. PubMed ID: 6256847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous mecillinam compared with other β-lactams as targeted treatment for Escherichia coli or Klebsiella spp. bacteraemia with urinary tract focus.
    Boel JB; Antsupova V; Knudsen JD; Jarløv JO; Arpi M; Holzknecht BJ
    J Antimicrob Chemother; 2021 Jan; 76(1):206-211. PubMed ID: 32989447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of sulfamethizole and amdinocillin against Escherichia coli strains (with various susceptibilities) in an ascending urinary tract infection mouse model.
    Kerrn MB; Frimodt-Møller N; Espersen F
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1002-9. PubMed ID: 12604534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amdinocillin in combination with beta-lactam antibiotics for treatment of serious gram-negative infections.
    Rotstein C; Farrar WE
    Am J Med; 1983 Aug; 75(2A):96-9. PubMed ID: 6311014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mecillinam in enteric fever.
    Mandal BK; Ironside AG; Brennand J
    Br Med J; 1979 Mar; 1(6163):586-7. PubMed ID: 218670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections.
    Jansåker F; Frimodt-Møller N; Sjögren I; Dahl Knudsen J
    J Antimicrob Chemother; 2014 Mar; 69(3):769-72. PubMed ID: 24107388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mecillinam-ampicillin synergism in experimental Enterobacteriaceae meningitis.
    Scheld WM; Fink FN; Fletcher DD; Sande MA
    Antimicrob Agents Chemother; 1979 Sep; 16(3):271-6. PubMed ID: 228591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of urinary tract infections with penicillin Hx].
    Swiderska-Kulikowa B; Zaleski A
    Pol Arch Med Wewn; 1981 Aug; 66(2):155-60. PubMed ID: 6275370
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy of ceftolozane/tazobactam versus levofloxacin in the treatment of complicated urinary tract infections (cUTIs) caused by levofloxacin-resistant pathogens: results from the ASPECT-cUTI trial.
    Huntington JA; Sakoulas G; Umeh O; Cloutier DJ; Steenbergen JN; Bliss C; Goldstein EJ
    J Antimicrob Chemother; 2016 Jul; 71(7):2014-21. PubMed ID: 26994090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A clinical investigation of pivmecillinam. A novel beta-lactam antibiotic in the treatment of urinary tract infections.
    Wise R; Reeves DS; Symonds JM; Wilkinson PJ
    Chemotherapy; 1976; 22(5):335-9. PubMed ID: 181216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of high-dose levofloxacin therapy remain bound to the levofloxacin minimum inhibitory concentration in complicated urinary tract infections.
    Armstrong ES; Mikulca JA; Cloutier DJ; Bliss CA; Steenbergen JN
    BMC Infect Dis; 2016 Nov; 16(1):710. PubMed ID: 27887579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of long-term treatment with mecillinam on fecal Escherichia coli.
    Møller JK; Stenderup A
    Scand J Infect Dis; 1984; 16(2):223-4. PubMed ID: 6330882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antibacterial activity of mecillinam against E. coli isolated from urinary tract infections (author's transl)].
    Shimizu Y
    Jpn J Antibiot; 1981 Jul; 34(7):1087-91. PubMed ID: 6275141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amdinocillin therapy of experimental animal infections.
    Gordin FM; Sande MA
    Am J Med; 1983 Aug; 75(2A):48-53. PubMed ID: 6311005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mecillinam, a new prophylactic for travellers' diarrhoea. A prospective double-blind study in tourists travelling to Egypt and the Far East.
    Black FT; Gaarslev K; Orskov F; Orskov I; Stenderup A; Stenderup J; Christensen O
    Scand J Infect Dis; 1983; 15(2):189-93. PubMed ID: 6308754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of amdinocillin and lack of nephrotoxicity when combined with a second beta-lactam antibiotic for therapy of serious gram-negative bacillary infections.
    Sattler FR; Hall S; Hanna CE; Green EA
    Am J Med; 1983 Aug; 75(2A):106-12. PubMed ID: 6310997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A fixed combination of pivmecillinam and pivampicillin in complicated urinary tract infections. Double-blind comparison with pivmecillinam alone in hospitalized patients.
    Scand J Infect Dis; 1983; 15(2):195-9. PubMed ID: 6308755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.